Global Idiopathic Pulmonary Fibrosis Market 2016-2020

2016-05-05
Price :
Published : May-2016
No. of Pages : 60

Idiopathic pulmonary fibrosis belongs to a group of lung diseases known as interstitial lung diseases. It affects people in the age group 50-70 years. Diagnosis is effected by the exclusion of other interstitial lung diseases. High-resolution computed tomography (CT) is often employed to confirm the presence of the disease. There is no permanent cure for this disease; therefore, treatment involves relieving underlying symptoms. Nintedanib and pirfenidone are the two approved drugs for the treatment of idiopathic pulmonary fibrosis. Corticosteroids and immunosuppressive drugs are also used for the treatment.

The analysts forecast global idiopathic pulmonary fibrosis market to grow at a CAGR of 23.97% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global idiopathic pulmonary fibrosis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of idiopathic pulmonary fibrosis.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

The report, Global Idiopathic Pulmonary Fibrosis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Baxter International
  • Boehringer Ingelheim
  • F.Hoffmann-La Roche
  • Prometheus Laboratories

Other prominent vendors

  • Afferent Pharmaceuticals
  • Amgen
  • Biogen
  • Bristol-Myers Squibb
  • Cipla
  • FibroGen
  • Gilead Sciences
  • GlaxoSmithKline
  • GNI Group
  • Horizon Pharma
  • ImmuneWorks
  • MediciNova
  • MedImmune (subsidiary of AstraZeneca)
  • Novartis
  • Pfizer
  • Promedior
  • ProMetic Life Sciences
  • Sanofi
  • Shionogi
  • Zai Lab

Market driver

  • Unmet medical need
  • For a full, detailed list, view our report

Market challenge

  • Lack of proper diagnosis
  • For a full, detailed list, view our report

Market trend

  • Patient assistance programs
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Therapeutics
Publisher : Technavio
More Reports
Title Price Buy Now

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Venezuela

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Venezuela Summary Venezuela ranked 187 out of 190 countries in ease of doing business. In July 2017, rating firm Standard & Poor's downgraded Venezuela's economy to CCC with a negative outlook. Moody's also downgraded its rating to Caa3 with a negative outlook, while Fitch rated it at CCC with a negative outlook. Venezuela is one of the emerging pharmaceutical markets in South America, with a major dependence on imports. However, economic and political turmoil along with inefficient patent laws and drug pricing policies are major barriers. The value of the market was US$12.6 Billion in 2015, having increased from US$5.7 Billion in 2009, at a Compound Annual Growth Rate (CAGR) of 14.1%. Drug prices in Venezuela are ......
$1995

Hemoglobinuria Global Clinical Trials Review, H2, 2017

Hemoglobinuria Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemoglobinuria Global Clinical Trials Review, H2, 2017" provides an overview of Hemoglobinuria clinical trials scenario. This report provides top line data relating to the clinical trials on Hemoglobinuria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. ......
$2500

Liver Failure (Hepatic Insufficiency) Global Clinical Trials Review, H2, 2017

Liver Failure (Hepatic Insufficiency) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Liver Failure (Hepatic Insufficiency) Global Clinical Trials Review, H2, 2017" provides an overview of Liver Failure (Hepatic Insufficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Failure (Hepatic Insufficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are ......
$2500

Hernia Global Clinical Trials Review, H2, 2017

Hernia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hernia Global Clinical Trials Review, H2, 2017" provides an overview of Hernia clinical trials scenario. This report provides top line data relating to the clinical trials on Hernia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated fro......
$2500

Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2017

Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2017" provides an overview of Hemophagocytic Lymphohistiocytosis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemophagocytic Lymphohistiocytosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated us......
$2500

Hepatic Veno Occlusive Disease Global Clinical Trials Review, H2, 2017

Hepatic Veno Occlusive Disease Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hepatic Veno Occlusive Disease Global Clinical Trials Review, H2, 2017" provides an overview of Hepatic Veno Occlusive Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatic Veno Occlusive Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's......
$2500

Herpesviridae Infections Global Clinical Trials Review, H2, 2017

Herpesviridae Infections Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Herpesviridae Infections Global Clinical Trials Review, H2, 2017" provides an overview of Herpesviridae Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Herpesviridae Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - ......
$2500

Hemophilia A Global Clinical Trials Review, H2, 2017

Hemophilia A Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemophilia A Global Clinical Trials Review, H2, 2017" provides an overview of Hemophilia A clinical trials scenario. This report provides top line data relating to the clinical trials on Hemophilia A. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical......
$2500

Hepatitis A Global Clinical Trials Review, H2, 2017

Hepatitis A Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hepatitis A Global Clinical Trials Review, H2, 2017" provides an overview of Hepatitis A clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis A. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500

Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H2, 2017

Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H2, 2017" provides an overview of Herpes Labialis (Oral Herpes) clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Labialis (Oral Herpes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's pro......
$2500